VTRNA2-1 and breast cancer: The tumour suppressor role of nc886 has been already previously related to a better prognosis of the disease in several neoplasia such as lung, ovarian, and breast cancer, among others [17,19,43,44,45], but this study was the first time that has been related to CRC.